1.94
2.02%
-0.04
eFFECTOR Therapeutics Inc Azioni (EFTR) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 |
Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
Revenues |
-
|
- | - | - | 0.675 |
Operating Expenses |
9.46%
8.598
|
7.855 | 7.855 | 9.536 | 9.398 |
Interest Income/Expense |
1.07%
0.758
|
0.75 | 0.722 | 0.689 | 0.697 |
Depreciation and Amortization |
426.51K%
110.92
|
0.026 | 0.027 | 0.028 | 52.97 |
Operating Income/Loss |
9.46%
-8.598
|
-7.855 | -7.855 | -9.536 | -8.723 |
Nonoperating Income/Loss |
18.75%
-0.532
|
-0.448 | -0.509 | -0.478 | -0.537 |
Income/Loss From Continuing Operations Before Tax |
9.96%
-9.13
|
-8.303 | -8.364 | -10.01 | -9.26 |
Income/Loss From Continuing Operations After Tax |
9.96%
-9.13
|
-8.303 | -8.364 | -10.01 | -9.26 |
Net Income/Loss
|
9.96%
-9.13
|
-8.303 | -8.364 | -10.01 | -9.26 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
178.39%
-48.42
|
61.77 | 47.83 | 42.00 | 0.1322 |
Diluted Average Shares |
178.39%
-48.42
|
61.77 | 47.83 | 42.00 | 0.1322 |
Basic Earnings Per Share |
12,085%
-15.84
|
-0.13 | -0.17 | -0.24 | -0.22 |
Diluted Earnings Per Share |
12,085%
-15.84
|
-0.13 | -0.17 | -0.24 | -0.22 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Capitalizzazione:
|
Volume (24 ore):